A study evaluating the efficacy and safety of the domestic SWAM embolectomy system in patients with moderate-risk acute pulmonary embolism

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2600124419

Enrollment

Unknown

Registered

2026-05-12

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate-risk acute pulmonary embolism

Interventions

Control group:anticoagulation alone

Experimental group:Surgical thrombectomy and anticoagulation therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years; 2.Diagnosed with acute moderate-risk PE within 48 hours by CTPA or other methods (according to ESC guidelines); 3.Signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Hemodynamic instability (high-risk PE); 2.active bleeding or anticoagulation contraindications; 3.pregnant or lactating women; 4.expected survival <3 months; 5.subjects deemed unsuitable for enrollment by the investigator.

Design outcomes

Primary

Measure	Time frame
TAPSE;	—

Secondary

Measure	Time frame
RV/LV ratio;PASP;TnI;Pulmonary Artery Obstruction Index;NT-proBNP;lung V/Q;	—

Countries

China

Contacts

Public ContactJiang Faming

West China Hospital of Sichuan University

jiangfam@163.com+86 28 85422376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026